Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 2
223
Views
11
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Identification and characterization of human UDP-glucuronosyltransferases responsible for xanthotoxol glucuronidation

, , , , , , , & show all
Pages 109-116 | Received 19 Dec 2016, Accepted 15 Jan 2017, Published online: 25 Jul 2017

References

  • Bubb WA. (2003). NMR spectroscopy in the study of carbohydrates: characterizing the structural complexity. Concept Magn Res 19A:1–19
  • Chen Y, Zhang G, Yu Z. (2006). The advancement in the chemical and pharmacological study of the fruits of Cnidium monnieri. J ShenYang Pharm Univ 23:256–60
  • Court MH, Zhang X, Ding X, et al. (2012). Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosytrasferase enzymes in 26 adult and 3 fetal tissues. Xenobiotica 42:266–77
  • Fallon JK, Smith PC, Neubert H, et al. (2013). Targeted precise quantification of 12 human recombinant Uridine-diphosphate glucuronosyltransferase 1A and 2B isoforms using nano-ultra-high-performance liquid chromatography/tandem mass spectrometry with selected reaction monitoring. Drug Metab Dispos 41:2076–80
  • He W, Chen W, Zhou Y, et al. (2013). Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia. Cell Mol Neurobiol 33:715–22
  • Kurkela M, Garcia-Horsman JA, Luukkanen L, et al. (2003). Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536–44
  • Kuuranne T, Kurkela M, Thevis M, et al. (2003). Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31:1117–24
  • Lake BG. (1999). Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol 37:423–53
  • Li Y, Jia M, Li H, et al. (2015). Cnidium monnieri: a review of traditional uses, phytochemical and ethnopharmacological properties. Am J Chin Med 43:835–77
  • Lian Q, Zhang Z, Shangguan Z, et al. (1996). Studies on the anti-arrhythmic effect of xanthotoxol in experimental animals. Chin Tradit Herb Drugs 27:347–9
  • Lian Q, Zhang Z, Hu X, et al. (1998). Studies on the anti-inflammatory effect of xanthotoxol in experimental animals. Chin Tradit Herb Drugs 29:102–4
  • Liang S, Xia Y, Hou J, et al. (2016). Methylation, glucuronidation, and sulfonation of daphnetin in human hepatic preparations in vitro: metabolic profiling, pathway comparison, and bioactivity analysis. J Pharm Sci 105:808–16
  • Lin N, Wang W, Tan W. (2014). Purifying xanthotol and osthole by medium pressure liquid chromatography. Mod Sci Instrum 10:142–6
  • Liu X, Liu J, Cai H, et al. (2014). Novel characterization of Radix Angelicae Dahuricae before and after the sulfur-fumigation process by combining high performance liquid chromatographic fingerprint and multi-ingredients determination. Pharmacogn Mag 10:338–45
  • Ma Z, Shi X, Zhang G, et al. (2016). Metabolism and metabolic inhibition of xanthotoxol in human liver microsomes. Evid-Based Complement Alternat 2:1–8
  • Mao Z, Meng X, Li Y, et al. (2011). Determination of xanthotoxol, bergapten, imperatorin and isoimperatorin in Angelicae Dahuricae Radix by HPLC. China Pharmacist 4:205–7
  • Marumoto S, Miyazawa M. (2012). Structure–activity relationships for naturally occurring coumarins as b-secretase inhibitor. Bioorg Med Chem 20:784–8
  • Matsuda H, Tomohiro N, Ido Y, et al. (2002). Anti-allergic effects of Cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol. Biol Pharm Bull 25:809–12
  • Ng TB, Liu F, Wang ZT. (2000). Antioxidative activity of natural products from plants. Life Sci 66:709–23
  • Ohno S, Nakajin S. (2008). Determination of mRNA expression of human UDP-Glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32–40
  • Sato Y, Nagata M, Tetsuka K, et al. (2014). Optimized methods for targeted peptide-based quantification of human uridine 5′-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry. Drug Metab Dispos 42:885–9
  • Sethi OP, Naik K. (1979). Xanthotoxol (XT) – a potent 5-HT antagonist. Indian J Physiol Pharmacol 23:142–3
  • Sethi OP, Anand KK, Gulatic OD. (1992). Evaluation of xanthotoxol for central nervous system activity. J Ethnopharmacol 36:239–47
  • Song W, Yu L, Peng Z. (2015). Targeted label-free approach for quantification of epoxide hydrolase and glutathione transferases in microsomes. Anal Biochem 478:8–13
  • Thelen K, Dressman JB. (2009). Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol 61:541–58
  • Troberg J, Järvinen E, Ge G, et al. (2016). UGT1A10 is a high activity and important extrahepatic enzyme-why has its role in intestinal glucuronidation been frequently underestimated? Mol Pharmaceut [online], December 1, 2016. Available from: http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00852 [Accessed 3 December 2016]
  • Walsky RL, Bauman JN, Bourcier K, et al. (2012). Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors. Drug Metab Dispos 40:1051–65
  • Wei Y, Zhang T, Ito Y. (2004). Preparative isolation of osthol and xanthotoxol from Common Cnidium Fruit (Chinese traditional herb) using stepwise elution by high-speed counter-current chromatography. J Chromatogr A 1033:373–7
  • Xia Y, Ge G, Wang P, et al. (2015). Structural modifications at the C-4 position strongly affect the glucuronidation of 6,7-dihydroxycoumarins. Drug Metab Dispos 43:553–60
  • Yang L, Ding W, Xu Y, et al. (2016). New insights into the antibacterial activity of hydroxycoumarins against Ralstonia solanacearum. Molecules 21:468
  • Zhu L, Ge G, Zhang H, et al. (2012). Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms. Drug Metab Dispos 40:529–38

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.